Foravirumab

Foravirumab
Monoclonal antibody
Type	Whole antibody
Source	Human
Target	rabies virus glycoprotein
Clinical data
ATC code	none;
Identifiers
CAS Number	944548-38-3 ☒;
ChemSpider	none;
UNII	377VY97V7S;
ChEMBL	ChEMBL1743021 ☒;
E number	{{#property:P628}}
CompTox Dashboard (EPA)	{{#property:P3117}}Lua error in Module:EditAtWikidata at line 29: attempt to index field 'wikibase' (a nil value).;
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 29: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C6400H9914N1718O1998S44
Molar mass	144304.38 g·mol−1
	☒check (what is this?) (verify)

Foravirumab is a monoclonal antibody for the prophylaxis of rabies.^[1] It is under development by Sanofi/Crucell.^[2]

References

^ International Nonproprietary Names for Pharmaceutical Substances (INN), World Health Organization.
^ Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).

This antiinfective drug article is a stub. You can help Wikipedia by expanding it.

This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it.